Hemoglobin A1c Monitoring Market - Global Strategic Business Report 2016 - Critical Role in Monitoring & Management of Diabetes

| Source: Research and Markets Research and Markets

Dublin, June 28, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Hemoglobin A1c Monitoring - Global Strategic Business Report" report to their offering.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

This report analyzes the worldwide markets for Hemoglobin A1c Monitoring in US$ by the following Test Types: HbA1c Laboratory Testing, and HbA1c Point of Care Testing.

The report profiles 25 companies including many key and niche players such as

  • Abbott Laboratories (US)
  • Alere, Inc. (US)
  • ARKRAY, Inc. (Japan)
  • Beckman Coulter, Inc. (US)
  • Bio-Rad Laboratories, Inc. (US)
  • Diazyme Laboratories Inc. (US)
  • EKF Diagnostics Holdings Plc (UK)
  • HemoCue® AB (Sweden)
  • Infopia Co., Ltd. (South Korea)
  • A.Menarini Diagnostics Ltd. (UK)
  • PTS Diagnostics (US)
  • Roche Diagnostics (Switzerland)
  • Siemens Healthineers (Germany)
  • Tosoh Bioscience, Inc. (US)
  • Trinity Biotech plc (Ireland)

Key Topics Covered:

1. MARKET OVERVIEW

  • HbA1c Devices: Critical Role in Monitoring & Management of Diabetes
  • Growth Stimulants in a Nutshell
  • Major Concerns
  • POC-based HbA1c Testing Challenges the Dominance of Laboratory-based HbA1c Testing Market
  • Increasing Diabetes Prevalence & Need for Diabetes Management to Prop-up Demand for HbA1c Testing Devices
  • High Risk of Diabetes in Aging Demographics Promises Growth in HbA1c Testing Devices Market
  • Increasing Obesity Levels Underpins Market Growth
  • Developing Nations: Growth Opportunities Abound for HbA1c Testing Market
  • Manufacturers Focus on Offering Products for Developing Markets
  • Increasing Healthcare Expenditure Aids Diabetes Diagnostics & Testing Market
  • Approval for HbA1c Testing for Diabetes Diagnosis: An Opportunity to Tap
  • Is HbA1c Test Right in Being Recommended for Diagnostic Purposes?
  • Technology Developments Transform Diagnostics in Diabetes Care
  • HbA1c Tests for Diabetes Diagnosis
  • Need to Address Issues Related to Hemoglobin Variants
  • Efforts Focus on Standardization Reporting of HbA1c Results
  • Consistent and Precise Test Results Favor Growth in the HbA1c Testing Devices Market
  • Glycosylated Hemoglobin Tests Pave the Way for Early-Stage Diabetes Diagnosis
  • Near Patient Testing Gaining Ground
  • Despite Reliability Issues, Prospects Remain Positive for POC Testing Market
  • Advantages of POC HbA1c Tests over Lab Tests to Foster Adoption
  • Major Testing Methods in POC HbA1c Tests
  • Immunoassays
  • Boronate Affinity Chromatography
  • Micro-Optical Detection Methods
  • Select HbA1c POC Tests in the Market
  • A Comparison
  • Home HbA1c Testing
  • Lack of Reimbursement Coverage & Accuracy Concerns Affect Adoption
  • Regular HbA1c Test Keeps Heart Risk at Bay
  • Glycated Albumin
  • A Potential Threat to HbA1c?
  • Higher Levels of Glycosylated Hemoglobin Increases Risk of Death
  • Non-Invasive Glucose Meters and CBGM Devices Threaten HbA1c Market
  • ESC and ADA Release Revised Guidelines for HbA1c Testing
  • Study Finds Dentist Visits to be an Opportunity for HbA1c- based Diabetes Screening & Management
  • Competitive Landscape
  • Select Laboratory-based HbA1c Testing Products/Analyzers
  • Select Point of Care HbA1c Testing Products/Analyzers

2. DIABETES - A BRIEF PROFILE OF THE DISEASE

  • What Causes Diabetes?
  • Types of Diabetes
  • Major Types of Diabetes
  • Likely Complications
  • Nephropathy (Kidney Disease)
  • Diabetic Neuropathy (Nerve Damage)
  • Retinopathy (Damage to the Eye and Blindness)
  • Poor Healing of Infections and Wounds
  • Impotence in Men
  • Periodontal Disease
  • Cardiovascular Disease
  • Interpreting the A1c Range
  • Blood Glucose Level Guidelines in the US
  • A Glance at Key Diabetes Statistics
  • Therapeutic Options for Diabetes
  • Oral Medications for Type 2 Diabetes
  • Side Effects of Insulin Therapy
  • Maintaining A1c Test Result Below 7%
  • Common Diabetes Management Practices

3. PRODUCT OVERVIEW

  • Hemoglobin
  • A Brief
  • Hemoglobin A1c- Description
  • HbA1c Monitoring
  • What is A1c?
  • 1. HbA1c Laboratory Testing
  • 2. HbA1c Point of Care Testing & Self-Monitoring
  • Hemoglobin A1c (HbA1c) Test
  • Interpreting HbA1c Test Readings
  • Interpreting HbA1c Test Readings
  • Result of Hemoglobin A1c Test
  • Clinical Use of A1c Testing
  • Advantages of A1c Assessment & Interpretation
  • Risks Associated with HbA1c Testing
  • Methods of Measurement for Glycohemoglobin
  • Why Opt for HbA1c Testing?
  • The Diabetes Control & Complications Trial (DCCT)
  • The Kumamoto and UK Prospective Studies
  • Glycemia Tests Used in Monitoring Diabetes
  • Urine Glucose Testing
  • Glycated Protein Testing
  • Table 22: Relation Between A1c Level and Mean Plasma Glucose Levels
  • HbA1c Test Types
  • HbA1c Laboratory Testing
  • Analytical Techniques Used for Quantifying HbA1c in Labs
  • Standardization of HbA1c Results
  • Table 23: CAP Accuracy Grading for HbA1c Measurements (2007-2013)
  • HbA1c Point of Care Testing & Self-Monitoring
  • Standardization of Glycated Hemoglobin Testing
  • NGSP Standardization of HbA1c
  • IFCC Standardization of HbA1c
  • HbA1c Reporting

4. PRODUCT INNOVATIONS/INTRODUCTIONS

  • ARKRAY Unveils New Instruments for HbA1c Measurement
  • Roche Introduces New Cobas C513 Analyser
  • ARKRAY Launches B-analyst HbA1c Control for HbA1c Tests
  • ARKRAY Unveils CinQ HbA1c Range of Reagent Kit
  • Transasia Bio-Medicals Introduces HbA1c & HbA2/F-Fully Automated Analyzer
  • ARKRAY Releases PocketChem A1c HbA1c Analyzer
  • Beckman Coulter Introduces Next-Generation Hemoglobin A1c
  • ARKRAY Unveils ADAMS A1c mini Glycated-Hemoglobin Analyzer
  • Axis-Shield Introduces HbA1c Turbidimetric Immunoassay
  • Abbott Introduces New A1c Test for Diabetes Diagnosis
  • Sanofi Introduces Self-Monitoring Device Offering HbA1c Values
  • ARKRAY Unveils ADAMS Hybrid AH-8290 Dual HbA1c and Glucose Analyzer
  • ARKRAY Releases ADAMS A1c HA-8180V and ADAMS A1c HA-8180T Analyzers
  • Sebia Unveils Capillarys HbA1c Assay

5. RECENT INDUSTRY ACTIVITY

  • Siemens Healthcare Rebrands as Siemens Healthineers
  • Sinocare to Acquire PTS Diagnostics
  • Abbott Inks Definitive Agreement to Takeover Alere
  • Bio-Rad Bags FDA Approval for D-100 System for A1c Testing
  • Bio-Rad's VARIANT II TURBO HbA1c Kit
  • 2.0 Receives FDA Approval for Use in Diabetes Diagnosis
  • Abnova Concludes Clinical Trial for Personal A1c Diabetes Rapid Test
  • Ortho-Clinical Diagnostics Obtains FDA Approval for VITROS® Chemistry Products HbA1c Reagent Kit
  • Abbott Gains FDA Approval for ARCHITECT Clinical Chemistry HbA1c Test
  • PTS Acquires Bayer's A1CNow® Product Family
  • Radiometer Acquires HemoCue
  • BioHermes Acquires HbA1c Technology from Scripps Laboratories

6. FOCUS ON SELECT PLAYERS

7. GLOBAL MARKET PERSPECTIVE

Total Companies Profiled: 25 (including Divisions/Subsidiaries 33)

  • The United States (15)
  • Japan (2)
  • Europe (13)
  • - Germany (3)
  • - The United Kingdom (4)
  • - Italy (1)
  • - Rest of Europe (5)
  • Asia-Pacific (Excluding Japan) (3)

For more information visit http://www.researchandmarkets.com/research/84w8mv/hemoglobin_a1c 



            











    

        

        
Contact Data